New findings regarding the influence of assistants on surgical outcomes in penile prosthesis implantation.
Shuo-Chieh WuAmanda R SwantonJames M JonesMartin S GrossPublished in: International journal of impotence research (2022)
Penile prosthesis implantation is the definitive treatment for refractory erectile dysfunction, yet exposure to this procedure during training of urology residents is often limited. To assess the effects of resident participation in penile prosthesis surgery, we compared surgical outcomes in a retrospective case series of 253 penile prosthesis surgeries by a single surgeon at the same institution between 2017 and 2020 with the assistance of either a registered nurse first assistant (RNFA) or a resident. Pertinent patient characteristics and surgical complications including device complications, surgical site infection, postoperative bleeding, iatrogenic injury, cardiovascular events, pulmonary events, and urinary retention were documented. Measured outcomes included operative time, Emergency Room (ER) visits, unplanned postoperative visits, pain medication refills, and surgical complications. Compared to RFNAs, resident-assisted penile prosthesis surgery was associated with significant increase in mean operative time (71.4 min vs. 87.9 min, p < 0.01) and postoperative ER visits (3.0% vs. 10.6%, p = 0.03) but not surgical complications (19.7% vs. 20.8%, OR 1.03, 95% CI [0.46 -2.30]) or other measured outcomes. Compared to a dedicated RFNA, Resident assistance increased operative time by approximately 17 min, but did not increase post-operative surgical complications, supporting the notion that resident assistance in these procedures may be appropriate as an integral part of training.
Keyphrases
- surgical site infection
- cardiovascular events
- patient safety
- minimally invasive
- quality improvement
- risk factors
- patients undergoing
- radical prostatectomy
- coronary artery disease
- healthcare
- emergency department
- prostate cancer
- coronary artery bypass
- primary care
- pulmonary hypertension
- cardiovascular disease
- chronic pain
- estrogen receptor
- type diabetes
- squamous cell carcinoma
- adipose tissue
- percutaneous coronary intervention
- radiation therapy
- breast cancer cells
- rectal cancer
- replacement therapy
- smoking cessation